Speaker Name: Prof. Reinhold Kreutz, Director, Department of Clinical Pharmacology & Toxicology, Berlin, Germany.

Watch this expert session to:

• Understand how ESH/WHO and ACC/AHA definitions influence hypertension diagnosis and treatment thresholds.
• Recognize optimal BP targets, including SBP 120–129 mmHg, and limits of intensive BP lowering.
• Identify key drivers of poor BP control, including therapeutic inertia, poor adherence, and delayed escalation.
• Evaluate single-pill combination therapy per ESH algorithm and MASTER protocol for improved BP control and adherence.
• Apply CLICK and related evidence to guide diuretic use in CKD and strengthen your approach to resistant hypertension management.